πŸ‡ΊπŸ‡Έ FDA
Patent

US 12409210

CNS delivery of therapeutic agents

granted A61KA61K35/76A61K35/761

Quick answer

US patent 12409210 (CNS delivery of therapeutic agents) held by Takeda Pharmaceutical Company Limited expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K35/76, A61K35/761, A61K38/46, A61K38/465